| ²é¿´: 490 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
pharmawangľ³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
ͲÛ---È«ÊÇÀÏ»¯ºÏÎsyncommÈ´ÈÃÎÒͨͨ²¹Ì¼Æ× ÒÑÓÐ1È˲ÎÓë
|
||
|
×î½üͶÁËһƪºÏ³É·½·¨Ñ§µÄÎÄÕµ½syncomm ÊǹØÓÚWittig·´Ó¦µÄ ¶¼¼¸ºõÕÒ²»µ½Ð»¯ºÏÎïºÏ³ÉÁË ËùÒÔÎÄÕÂÖеϝºÏÎï¶¼ÊÇÀÏ»¯ºÏÎﱨµÀз½·¨ºÏ³É¶øÒÑ µ«ÊÇÔÓÖ¾µÄ´¦Àí½á¹ûÊÇ"Reject & Resubmit" ±à¼¾ÓÈ»ÈÃÎÒ²¹ÉÏËùÓеÄ̼Æ×Êý¾ÝÔÙËÍÉó Please resubmit your manuscript with supporting C NMR Spectra to facilitate the reviewing process. You will be unable to make your revisions on the originally submitted version of your manuscript. Instead, you will need to re-submit the new version of the manuscript. »¹ËµBecause we are trying to facilitate timely publication of manuscripts submitted to Synthetic Communications, your revised manuscript should be uploaded as soon as possible. If it is not possible for you to submit your revision within a reasonable amount of time, we will consider your paper as a new submission. ²»ÖªµÀ»¹ÐèÒª¸ø±à¼»Ø¸´Óʼþ»òд³·¸åÐÅÂ𣿠[ Last edited by pharmawang on 2014-2-3 at 18:55 ] |
» ²ÂÄãϲ»¶
297Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
26µ÷¼Á 086003
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
271·ÖÇóµ÷¼ÁѧУ
ÒѾÓÐ11È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ8È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö
ÒѾÓÐ15È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
pharmawang
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 4678.9
- É¢½ð: 28
- ºì»¨: 1
- Ìû×Ó: 1335
- ÔÚÏß: 180.3Сʱ
- ³æºÅ: 266946
- ×¢²á: 2006-07-22
- ÐÔ±ð: GG
- רҵ: ÂÌÉ«Óлú»¯Ñ§
3Â¥2014-02-03 18:25:31
kingki
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 465 (˶ʿ)
- ½ð±Ò: 23654.3
- É¢½ð: 6301
- ºì»¨: 18
- Ìû×Ó: 7935
- ÔÚÏß: 601.3Сʱ
- ³æºÅ: 514983
- ×¢²á: 2008-02-29
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§

2Â¥2014-02-03 18:16:45














»Ø¸´´ËÂ¥